NCT07548866

Brief Summary

The study aims to identify the advantages and disadvantages of each of the three methods of airway management during FESS.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Apr 2026Feb 2027

Study Start

First participant enrolled

April 1, 2026

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 16, 2026

Last Update Submit

April 24, 2026

Conditions

Keywords

Laryngeal mask airwayTracheal intubationAirway anesthesiaFESS

Outcome Measures

Primary Outcomes (1)

  • cough severity and frequencies

    Coughing was scored as mild (single cough), moderate (\>1 episode of un- sustained coughing lasting 5 seconds), or severe (sustained, \>5 seconds, bouts of coughing). Target values - mild cough.

    15 minutes after waking up

Secondary Outcomes (2)

  • Richmond agitation-sedation scale (RASS)

    15 minutes after waking up

  • The Ramsay scale

    15 minutes after waking up

Study Arms (3)

LMA (1)

the laryngeal mask was installed intraoperatively

Device: laryngeal mask placement

TI (2)

tracheal intubation was performed intraoperatively

Device: tracheal intubation

TIL (3)

intraoperative tracheal intubation and respiratory tract anesthesia were performed

Drug: anesthesia of the respiratory tract with lidocaine

Interventions

administration of 4% lidocaine during tracheal intubation

TIL (3)

intraoperative tracheal intubation

TI (2)

intraoperative placement of a laryngeal mask

LMA (1)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

adult patients who underwent FESS under general anesthesia

You may qualify if:

  • general anesthesia during fess

You may not qualify if:

  • history of mental and neurological diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pavlov First Saint Petersburg State Medical University

Saint Petersburg, 197022, Russia

Location

MeSH Terms

Interventions

LidocaineIntubation, Intratracheal

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAirway ManagementTherapeuticsIntubationInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Assistant professor

Study Record Dates

First Submitted

April 16, 2026

First Posted

April 23, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

only statistical processing of an unnamed data array is planned

Locations